Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: Case report and review of the literature

Ultrasound in Obstetrics and Gynecology

Volumn 18, Issue 1, 2001, Pages 62-66

  Meyer Wittkopf, M ^a   Barth, H ^a   Emons, G ^a   Schmidt, S ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Breast carcinoma; Chemotherapy; Fetal heart; Pregnancy

Indexed keywords

DOXORUBICIN;

ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CASE REPORT; DRUG EFFECT; FETUS; HUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DOXORUBICIN; FEMALE; FETUS; HEART; HUMANS; MASTECTOMY, MODIFIED RADICAL; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY, HIGH-RISK;

EID: 0034922599     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.2001.00373.x     Document Type: Article

References (32)

1. Breast disease complicating pregnancy
2. Breast cancer and pregnancy
3. Cytotoxic therapy and pregnancy
4. Chemotherapy in pregnancy
5. Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children
6. Long-term follow-up of children exposed in utero to anti-neoplastic agents
7. Maternal and fetal outcome after breast cancer in pregnancy
8. Treating breast cancer during pregnancy. What can be taken safely?
9. Doxorubicin-induced cardiomyopathy
10. Risk factors for doxorubicin-induced congestive heart failure
11. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
12. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia
13. Changes in intracardiac blood flow velocities and right and left ventricular stroke volumes with gestational age in the normal human fetus: A prospective Doppler echocardiographic study
14. Human fetal tricuspid and mitral deceleration time: Changes with normal pregnancy and intrauterine growth retardation
15. Determinants of the Doppler flow velocity profile through the mitral valve of the human fetus
16. Diastolic function of the fetal heart during second and third trimester: A prospective longitudinal Doppler-echocardiographic study
17. Gestational age- and growth-related alterations in fetal right and left ventricular diastolic filling patterns
18. Quantitative assessment of growth and function of the cardiac chambers in the normal human fetus: A prospective longitudinal echocardiographic study
19. Echocardiographic evaluation of dilated cardiomyopathy in the human fetus
20. Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies
21. M-mode echocardiographic evaluation of fetal and infant hearts: Longitudinal follow-up study from intrauterine life to year one
22. Carcinoma of the breast associated with pregnancy
23. Management of the pregnant patient with carcinoma of the breast
24. Management of breast cancer during pregnancy using a standardized protocol
25. Pharmacology of antineoplastic agents in pregnancy
26. Cardiac dimensions determined by cross-sectional echocardiography in the normal human fetus from 18 weeks to term
27. Fetal cardiac size in normal, intrauterine growth retarded, and diabetic pregnancies
28. Two-dimensional echocardiographic evaluation of ventricular systolic function in human fetuses with ductal constriction
29. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience
30. Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study
31. Anthracycline-induced cardiotoxicity
32. Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler echocardiographic findings and pathophysiologic implications